Russia moves personalised mRNA cancer vaccines into early clinical use (For illustration purposes only) Tara Winstead: Pexels Russia's advancing programme of personalised mRNA cancer vaccines has ...
The first patient to receive Russia’s personalized melanoma vaccine is feeling well and has developed the immune response needed to fight the disease, said Aleksandr Ginzburg, the scientific director ...
It is planned to obtain permission for the use of two glioblastoma vaccines in 2026. This was announced on June 9 by Veronika Skvortsova, head of the Federal Medical and Biological Agency. "In 2026, I ...
Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses, overturning a long-held assumption about how the vaccines work. The ...
First, pancreatic cancer. Now melanoma. A treatment for the former, announced in May, at the American Society of Clinical Oncology Annual Meeting, and which this column wrote about on June 12th, has ...